Safety and efficacy of linagliptin in patients with type 2 diabetes and coronary artery disease: analysis of pooled incident investigator-reported events from phase 3 trialsM. Lehrke,L. A. Leiter, U. Hehnke,S. Thiemann,O. E. Johansen,A. Bhandari,S. Patel,H. -J. WoerleDIABETOLOGIA（2015）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
